London Urologist Vinod Nargund

Publications

1 Nargund V, Naik K G: Parotid Tumours: Clinico-pathological study. Antiseptic. 1981; 32: 93-7

2 Schraibman I G, Micheal Z, Nargund V H and Potdar N: Colonoscopic surveillance after diagnosis of carcinoma of colon and rectum. Annales de Chirurgie 1989; 43(7): 568-9

3* Nargund VH, Lomas K, Sapherson DA, Flannigan GM, Stewart PA: Radiographer-performed abdominal and pelvic ultrasound: Its value in urology out-patient clinic. British Journal of Urology 1994;73: 366-70

4* Nargund V H, Barker I K, Coombs L, Flannigan G M, Hamilton Stewart P A and Crawford S M: Growth characteristics of early passage cell lines compared with established TCC bladder cell lines. Urological Research 1994; 22:75 -7

5 Nargund V H, Hamilton Stewart P A : Point of technique: Endoscopic Localisation of the lesion prior to partial cystectomy. British Journal of Urology 1994; 73(4): 455-6

6 Nargund V H, Hockley I, Flannigan G M: Point of technique Extracorporeal shock wave lithotripsy for lower ureteric stones through perineal region. British Journal of Urology 1995; 75; 410

7 Nargund V H, Cumming J A, Jerwood D, Sapherson D A, Hamilton Stewart P A and Flannigan G M. Ultrasound in urological emergency: results of self audit and implications for training. International Urology and Nephrology 1996; 28; 267-71

8 Sugino T, Gorham H, Yoshida K, Boledeoku J, Goodison S, Nargund V, Cranston D and Tarin D. Progressive loss of Cd44 gene expression in invasive bladder cancer. American Journal of Pathology 1996; 149: 873-82

9 Nargund V H and Cranston D W. Urological complications in renal transplantation. Transplant Reviews 1996; 10: 24-33 (Review)

10 Yoshida K, Sugino T, Tahara H, Nargund V H, Woodman A, Fellows G J and Tarin D. Telomerase activity in bladder carcinoma and its implications for non-invasive diagnosis by its detection in exfoliated cancer cells in urine. Cancer 1997; 79: 362-369

11 Nargund V H, Lowe J, Flanagan G and Hamilton Stewart P. Role of P-Glycoprotein in chemo-resistant superficial bladder tumours. European Urology 1997; 31: 160-2

12* Robertson A J, Nargund V, Gray D W R, Morris P J. Low dose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant patients. Nephrology, Dialysis and Transplantation 2000; 15: 1865-8

13 Fenely M, Jan H, Granowska S J, Mather S, Ellison D, Kirby R S, Oliver R T D, Badenoch D F, Chinegwundoh F C, Nargund V H, Paris A M I and Britton K E. Imaging with prostate specific membrane antigen (PSMA) in prostate cancer. Prostatic carcinoma and Prostatic diseases 2000; 3: 47-52 (Review)

14 Nargund V H, Noble J G, Cranston D and Fellows G J. Haematuria: A long-term problem after prostatectomy. Urologia Internationalis 2001; 66: 1-5

15 Ojha K, Nargund V H, Nargund G. Emergency sperm extraction for transient erectile dysfunction prior to assisted conception. Journal of Assisted Reproduction and Genetics 2001; 18: 36-7

16 Otite U, Webb J A W, Oliver R T D, Badenoch D F and Nargund V H. Testicular microlithiasis: Is it a benign condition with a malignant potential? European Journal of Urology 2001; 40: 538-42

17 Goonewardene T I, Bozcuk H, Oliver R T, Barua J, Nargund V and Philip T. Phase 1/2 Study of Synchronous Methotrexate, Cisplatin, Vincristine (MOPq10) Chemotherapy and radiation for patients with locally advanced bladder cancer. Urologia Internationalis 2001; 67: 293-7

18 Sohaib A, Theo J, Nargund V H, Hendry W F, Lumley J and Reznek R. Role of MRI in the evaluation of vena caval involvement of renal cell carcinoma. Journal of Urology 2002; 167: 1271-5

19 Nargund V H. Management of testicular pain. The Practitioner 2002;246:792-800

20 Oliver RTD, Ong J, Berney D, Nargund V, Badenoch D and Samash J. Testis conserving chemotherapy in gern cell cancer: Its potential to increase understanding of the biology and treatment of carcinoma in situ. Acta Pathologica Microbiologica et Immunologica Scandanavia 2003: 111: 86-91[Meta-analysis]; discussion 91-2

21 Nargund V H. Editorial comment: Flutamide in recurrent prostate cancer. British Journal of Urology International 2003; 92: 698

22 Oliver R T D, Ong J, Shamash J, Ravi R, Nargund V, Harper P, Ostroveski M J, Sizer B, LeVay J, Robinson A, Neal D E, Williams M. Long-term follow up of Anglian germ cell cancer group surveillance versus patients with stage I non-seminoma treated with adjuvant chemotherapy. Urology 2004; 63: 556-61

23 Hitchings A W, Kumar M, Jordan S, Nargund V, Martin J and Berney D M. Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb. British Journal of Cancer 2004; 91: 552-7

24 Lucas M, Stephenson T and Nargund V H. Tamsulosin in the management of patients in acute urinary retention due to BPH. British Journal of Urology International 2005;95:354-7

25 Nargund V H, Al-Hashimi D, Kumar P, Gordon S, Otite U, Ellison D, Carroll M, Baithun S, Britton K. Imaging with radio-labelled monoclonal antibody (MUJ 591) to prostate-specific membrane antigen (PSMA) in staging of clinically localised prostatic carcinoma: Comparison with clinical, surgical and histological staging. British Journal of Urology International 2005; 95: 1232-6

26 Bhardwa J, M, Powell R, Berney D, Baithun S, Nargund V H, Oliver R T D. Assessing the size and stage of testicular germ cell tumours 1984-2003. British Journal of Urology International 2005 ; 96:819-21

27 Otite U, Baithun S, Chinegwundoh F C, Nargund V H, Iles R K, Detection of serum and urinary beta human chorionic gonadotrophin (hCGb) in serum or urine is of no clinical significance. Tumor Biology 2006; 27 (4): 181-6

28 Ghani K, Rockall A, Nargund V H, Chinegwundoh F. Comments: Prostate Biopsy: To stop anticoagulation or not? British Journal of Urology International 2006; 97(2): 224-5

29 Kumar P and Nargund V H. Samuel Pepys: A Patient's Perspective of Lithotomy in 17th Century England. Journal of Urology 2006; 175(4): 1221-4 (Review)

30. Kumar P, Kapoor S, Nargund V. Review: Haematospermia. Annals of Royal College of Surgeons of England 2006; 88 (4): 339-42

31 Chinegwundoh F C, Enver M K, Oliver R T D, Nargund V H and Ben-Shlomo Y. Risk and presenting features of prostate cancer amongst African Caribbeans, South Asians and Europeans in Northeast London. British Journal of Urology International (In press).

32 Kumar P and Nargund V H. Point of technique: Management of post-radical prostatectomy anastomotic stricture by endoscopic transurethral balloon dilatation. Scandinavian Journal of Urology and Nephrology (In press)

Books, Booklets, Presentations and Proceedings:

Case Reports and Letters

Published Abstracts (Journals)




				Publications Peer-reviewed Papers 1 Nargund V, Naik K G: Parotid Tumours: Clinico-pathological study. Antiseptic. 1981; 32: 93-7 2 Schraibman I G, Micheal Z, Nargund V H and Potdar N: Colonoscopic surveillance after diagnosis of carcinoma of colon and rectum. Annales de Chirurgie 1989; 43(7): 568-9 3* Nargund VH, Lomas K, Sapherson DA, Flannigan GM, Stewart PA: Radiographer-performed abdominal and pelvic ultrasound: Its value in urology out-patient clinic. British Journal of Urology 1994;73: 366-70 4* Nargund V H, Barker I K, Coombs L, Flannigan G M, Hamilton Stewart P A and Crawford S M: Growth characteristics of early passage cell lines compared with established TCC bladder cell lines. Urological Research 1994; 22:75 -7 5 Nargund V H, Hamilton Stewart P A : Point of technique: Endoscopic Localisation of the lesion prior to partial cystectomy. British Journal of Urology 1994; 73(4): 455-6 6 Nargund V H, Hockley I, Flannigan G M: Point of technique Extracorporeal shock wave lithotripsy for lower ureteric stones through perineal region. British Journal of Urology 1995; 75; 410 7 Nargund V H, Cumming J A, Jerwood D, Sapherson D A, Hamilton Stewart P A and Flannigan G M. Ultrasound in urological emergency: results of self audit and implications for training. International Urology and Nephrology 1996; 28; 267-71 8 Sugino T, Gorham H, Yoshida K, Boledeoku J, Goodison S, Nargund V, Cranston D and Tarin D. Progressive loss of Cd44 gene expression in invasive bladder cancer. American Journal of Pathology 1996; 149: 873-82 9 Nargund V H and Cranston D W. Urological complications in renal transplantation. Transplant Reviews 1996; 10: 24-33 (Review) 10 Yoshida K, Sugino T, Tahara H, Nargund V H, Woodman A, Fellows G J and Tarin D. Telomerase activity in bladder carcinoma and its implications for non-invasive diagnosis by its detection in exfoliated cancer cells in urine. Cancer 1997; 79: 362-369 11 Nargund V H, Lowe J, Flanagan G and Hamilton Stewart P. Role of P-Glycoprotein in chemo-resistant superficial bladder tumours. European Urology 1997; 31: 160-2 12* Robertson A J, Nargund V, Gray D W R, Morris P J. Low dose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant patients. Nephrology, Dialysis and Transplantation 2000; 15: 1865-8 13 Fenely M, Jan H, Granowska S J, Mather S, Ellison D, Kirby R S, Oliver R T D, Badenoch D F, Chinegwundoh F C, Nargund V H, Paris A M I and Britton K E. Imaging with prostate specific membrane antigen (PSMA) in prostate cancer. Prostatic carcinoma and Prostatic diseases 2000; 3: 47-52 (Review) 14 Nargund V H, Noble J G, Cranston D and Fellows G J. Haematuria: A long-term problem after prostatectomy. Urologia Internationalis 2001; 66: 1-5 15 Ojha K, Nargund V H, Nargund G. Emergency sperm extraction for transient erectile dysfunction prior to assisted conception. Journal of Assisted Reproduction and Genetics 2001; 18: 36-7 16 Otite U, Webb J A W, Oliver R T D, Badenoch D F and Nargund V H. Testicular microlithiasis: Is it a benign condition with a malignant potential? European Journal of Urology 2001; 40: 538-42 17 Goonewardene T I, Bozcuk H, Oliver R T, Barua J, Nargund V and Philip T. Phase 1/2 Study of Synchronous Methotrexate, Cisplatin, Vincristine (MOPq10) Chemotherapy and radiation for patients with locally advanced bladder cancer. Urologia Internationalis 2001; 67: 293-7 18 Sohaib A, Theo J, Nargund V H, Hendry W F, Lumley J and Reznek R. Role of MRI in the evaluation of vena caval involvement of renal cell carcinoma. Journal of Urology 2002; 167: 1271-5 19 Nargund V H. Management of testicular pain. The Practitioner 2002;246:792-800 20 Oliver RTD, Ong J, Berney D, Nargund V, Badenoch D and Samash J. Testis conserving chemotherapy in gern cell cancer: Its potential to increase understanding of the biology and treatment of carcinoma in situ. Acta Pathologica Microbiologica et Immunologica Scandanavia 2003: 111: 86-91[Meta-analysis]; discussion 91-2 21 Nargund V H. Editorial comment: Flutamide in recurrent prostate cancer. British Journal of Urology International 2003; 92: 698 22 Oliver R T D, Ong J, Shamash J, Ravi R, Nargund V, Harper P, Ostroveski M J, Sizer B, LeVay J, Robinson A, Neal D E, Williams M. Long-term follow up of Anglian germ cell cancer group surveillance versus patients with stage I non-seminoma treated with adjuvant chemotherapy. Urology 2004; 63: 556-61 23 Hitchings A W, Kumar M, Jordan S, Nargund V, Martin J and Berney D M. Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb. British Journal of Cancer 2004; 91: 552-7 24 Lucas M, Stephenson T and Nargund V H. Tamsulosin in the management of patients in acute urinary retention due to BPH. British Journal of Urology International 2005;95:354-7 25 Nargund V H, Al-Hashimi D, Kumar P, Gordon S, Otite U, Ellison D, Carroll M, Baithun S, Britton K. Imaging with radio-labelled monoclonal antibody (MUJ 591) to prostate-specific membrane antigen (PSMA) in staging of clinically localised prostatic carcinoma: Comparison with clinical, surgical and histological staging. British Journal of Urology International 2005; 95: 1232-6 26 Bhardwa J, M, Powell R, Berney D, Baithun S, Nargund V H, Oliver R T D. Assessing the size and stage of testicular germ cell tumours 1984-2003. British Journal of Urology International 2005 ; 96:819-21 27 Otite U, Baithun S, Chinegwundoh F C, Nargund V H, Iles R K, Detection of serum and urinary beta human chorionic gonadotrophin (hCGb) in serum or urine is of no clinical significance. Tumor Biology 2006; 27 (4): 181-6 28 Ghani K, Rockall A, Nargund V H, Chinegwundoh F. Comments: Prostate Biopsy: To stop anticoagulation or not? British Journal of Urology International 2006; 97(2): 224-5 29 Kumar P and Nargund V H. Samuel Pepys: A Patient's Perspective of Lithotomy in 17th Century England. Journal of Urology 2006; 175(4): 1221-4 (Review) 30. Kumar P, Kapoor S, Nargund V. Review: Haematospermia. Annals of Royal College of Surgeons of England 2006; 88 (4): 339-42 31 Chinegwundoh F C, Enver M K, Oliver R T D, Nargund V H and Ben-Shlomo Y. Risk and presenting features of prostate cancer amongst African Caribbeans, South Asians and Europeans in Northeast London. British Journal of Urology International (In press). 32 Kumar P and Nargund V H. Point of technique: Management of post-radical prostatectomy anastomotic stricture by endoscopic transurethral balloon dilatation. Scandinavian Journal of Urology and Nephrology (In press) Books, Booklets, Presentations and Proceedings: Case Reports and Letters Published Abstracts (Journals)